Ixekizumab treatment of patients with moderate-to-severe plaque psoriasis.

ABSTRACT: Ixekizumab treatment of patients with moderate-to-severe plaque psoriasis.

PROVIDER: PRJNA737931 | ENA |

REPOSITORIES: ENA